PROMETHEUS BIOSCIENCES, INC. Deferred Tax Assets, Net of Valuation Allowance
PROMETHEUS BIOSCIENCES, INC. had Deferred Tax Assets, Net of Valuation Allowance of $7.97 million as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2023-02-28
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $7.97M.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $67.00K.
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $29.00K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2022-12-31 | $7.97M 10-K · filed 2023-02-28 |
| 2021-12-31 | $67.00K 10-K · filed 2023-02-28 |
| 2020-12-31 | $29.00K 10-K · filed 2022-03-09 |